Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government Life Science Investing News
Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application Pharmaceutical Investing
FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults With Type 1 Diabetes Pharmaceutical Investing
Vaccinex Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 Biotech Investing
Inspire Medical Systems Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey Medical Device Investing
Cryopreservation Company, Acorn Biolabs Closes $3.3M Seed Funding and Ramps Towards Consumer Launch Biotech Investing
Altria Group Invests Up to $12M in Lexaria Bioscience’s DehydraTECH(TM) Technology Cannabis Investing News
